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Abstract
We performed a genome-wide association scan on the North American Rheumatoid Arthritis
Consortium (NARAC) data using Hotelling’s T2 tests, i.e., TH based on allele coding and TG based on
genotype coding. The objective was to identify associations between single-nucleotide
polymorphisms (SNPs) or markers and rheumatoid arthritis. In specific candidate gene regions,
we evaluated the performance of Hotelling’s T2 tests. Then Hotelling’s T2 tests were used as a tool
to identify new regions that contain SNPs showing strong associations with disease. As expected,
the strongest association evidence was found in the region of the HLA-DRB1 locus on
chromosome 6. In the region of the TRAF1-C5 genes, we identified two SNPs, rs2900180 and
rs3761847, with the largest and the second largest TH and TG scores among all SNPs on
chromosome 9. We also identified one SNP, rs2476601, in the region of the PTPN22 gene that had
the largest TH score and the second largest TG score among all SNPs on chromosome 1. In addition,
SNPs with the largest TH score on each chromosome were identified. These SNPs may be located
in the regions of genes that have modest effects on rheumatoid arthritis. These regions deserve
further investigation.
Background
Rheumatoid arthritis (RA) is the most common inflam-
matory joint disease and has an autoimmune etiology.
The exact cause of RA is still unknown, but it is well
known that RA has a strong genetic component [1]. The
HLA-DRB1 locus has been clearly demonstrated to be
associated with RA [2-4]. Other candidate genes, such as
PTPN22 and TRAF1-C5, which confer a modest level of
risk of RA, have also been identified recently [5,6]. We
conducted a genome-wide association analysis on the
data of the North American Rheumatoid Arthritis
Consortium (NARAC). The objective of this analysis
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was to identify associations between single-nucleotide
polymorphisms (SNPs) or markers and RA. In specific
candidate gene regions, we evaluated the performance of
Hotelling’s T2 tests on known associations. Then, we
used the Hotelling’s T2 tests to identify additional SNPs
that showed strong association with RA. These SNPs are
located in regions that are very likely related to the
disease and deserve further investigation.
Methods
We used the Hotelling’s T2 test developed by Fan and
Knapp [7] and Xiong et al. [8] to analyze the NARAC
data. Consider a case-control design with N cases from
an affected population and M controls from an
unaffected population. When analyzing SNPs, we study
bi-allelic markers with two alleles, which we denoted by
1 and 2 that can form three genotypes 1/1, 1/2 and 2/2.
Then a coding vector can be defined for each case/
control by either i) genotype coding or ii) allele coding.
Let Xi and Yj denote the coding vector for the i
th case and
the jth control, respectively. In our study, Xi = (1,0)
τ for
genotype 1/1, Xi = (1,0)
τ for genotype 1/2, and Xi = (0,0)
τ
for genotype 2/2 were used in the genotype coding,
whereas the allele coding simply counts the number of
allele 1 of a genotype. If multiple markers are available,
the coding vectors of each case/control can be combined
together. For instance, the allele coding vector of a case/
control of n SNPs is an n-dimensional vector; and the
genotype coding vector of a case/control of n SNPs is 2n-
dimensional. For multi-allelic markers, the coding
method is described by Fan and Knapp [7]. Let us define
a pooled-sample variance covariance matrix by
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In the following, we will denote the Hotelling’s T2 for
allele coding as TH and the Hotelling’s T
2 for genotype
coding as TG. Assume the sample sizes N and M are large
enough so that the large sample theory applies. Under
the null hypothesis of no association, the statistic TH (or
TG) is asymptotically distributed as a central chi-square
c2 statistic with n (or 2n) degree(s) of freedom if n SNPs
are used in the analysis. Under the alternative hypothesis
of association, TH (or TG) is asymptotically distributed as
a non-central chi-square c2 statistic [7,8,10].
Based on the Hotelling’s T2 test statistics, we have
developed a SAS Macro (hotel_cc.sas) to implement the
method, which is available online [11].
Results
First, we applied the Hotelling’s test statistics and
performed a genome-wide scan on the NARAC data by
analyzing one SNP at a time. The NARAC data contained
a total of 2062 individuals (868 cases and 1194
controls). Our analysis used data from 22 autosomes.
The RA data of Genetic Analysis Workshop (GAW) 16
included 545,080 SNP-genotype fields from an Illumina
550 k chip (22 autosomes, sex chromosomes, and
mitochondria). We dropped all SNPs with low call
rates (less than 95%) or not in Hardy-Weinberg
equilibrium in the controls (p-value < 10-5) and dropped
all SNPs which are not on the autosomes. After this
filtering, 490,613 SNPs on 22 autosomes were used in
our analysis. The strongest signal was found in the region
of the HLA-DRB1 gene on chromosome 6 at location
32,654,524-32,686,031 bp. In Figure 1, Graphs I and II
show the Hotelling’s test scores for chromosome 6. Both
TH and TG scores reached the highest value around the
location of 32.5 Mb in the region of HLA-DRB1. Graphs
III and IV showed the results in the region of HLA-DRB1
gene (the legend indicates location of the HLA-DRB1
gene). Most of the test scores in the region were very
significant.
We present the six SNPs on chromosome 6 with the
highest test scores in the left-hand part of Table 1. The
most significant result was found at SNP rs2395175
(p-value = 9.25 × 10-144). These SNPs are all located
around the HLA-DRB1 gene. It is interesting that both TH
and TG reached the highest scores at the same four SNPs
(rs2395175, rs660895, rs6910071, and rs2395163).
Interstingly, TH reached the 5
th highest score at SNP
rs3763309 and the 6th highest at SNP rs3763312;
conversely, TG reached the 5
th highest score at SNP
rs3763312 and the 6th highest at SNP rs3763309.
Actually, the order of two SNPs for TH and TG that
reached the 7th and 8th highest scores switches too; in
addition, TH and TG reached the 9
th to 13th highest scores
at the same SNPs (data not shown). Thus, the region of
the HLA-DRB1 gene contains multiple SNPs that are
highly associated with RA. In addition, the p-values of
the test TG were generally smaller than those of TH, i.e.,
the genotype coding test TG leads to more significant
results than the allele coding test TH. This observation is
consistent with the evidence for non-additivity of DRB1
effects [12].
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It is well known that the HLA-DRB1 alleles are associated
with RA [1,2]. We performed an analysis in which HLA-
DRB1 alleles *0101, *0102, *0401, *0404, *0405,
*0408, *1001, which are components of the shared
epitope were treated as risk alleles, and the other alleles
were collapsed as one. Here we used the multi-allelic
version of the Hotelling’s T2 tests [7]. The test score for
allele coding was TH = 650.81 with 7 degrees of freedom
(p-value = 2.76 × 10-136), and test score for genotype
coding was TG = 694.82 with 35 degrees of freedom
(p-value = 1.36 × 10-123). The results were consistent
with those using individual SNPs above. On the basis of
individual SNP analysis, we performed a forward
analysis of multiple SNPs. Using the most significant
Figure 1
Hotelling's test scores for chromosomes 6 and 9 data.
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SNP rs2395175 as baseline, we added one SNP a time for
an analysis of two SNPs. We identified that each of three
SNPs, rs660895, rs6910071, and rs3763312, contributed
significant association in addition to the contribution of
the base SNP rs2395175 (p-value < 0.01). Moreover, the
most significant result was from the two SNPs rs2395175
and rs660895. Then, we added one SNP at a time to the
two most significant SNPs; we found each of the two
SNPs, rs6910071 and rs3763312, contributed significant
association (p-value < 0.01). Finally, four SNPs together
were found to be significantly associated with RA
(rs2395175, rs660895, rs6910071 and rs3763312;
p-value < 0.01).
Graphs V-VIII of Figure 1 showed the results of
chromosome 9 (the legend indicates location of the-
TRAF1-C5 genes). In Plenge et al. [6], SNP rs3761847 at
position 120,769,793 bp and SNP rs2900180 at position
120,785,936 bp were found to be significantly associated
with RA in the region of the TRAF1-C5 genes. We found
consistent results since TH = 34.21 of SNP rs2900180 was
the largest (p-value = 4.95 × 10-9), and TH = 32.17 of SNP
rs3761847 was the second largest among all SNPs on
chromosome 9 (p-value = 1.41 × 10-8). Other SNPs on
chromosome 9 that showed highest scores were also
reported on the right-hand side of Table 1. Interestingly,
the SNPs identified via TH were the same as the ones
identified via TG (the right-hand side of Table 1). As with
chromosome 6 in the region HLA-DRB1, we performed a
forward analysis of multiple SNPs. Using rs2900180 as
baseline, we found no other SNP that contributed
significant association (p-value > 0.05). Thus, all
association is from SNP rs2900180 in the region of the
TRAF1-C5 genes.
In the region of the PTPN22 gene on chromosome 1, we
identified one SNP (rs2476601) that was reported to be
associated with RA by Begovich et al. [5]. The SNP is
located at position 114,089,610 bp on the left-hand side
of the PTPN22 gene. The TH = 48.88 of rs2476601 was
the largest TH score among all SNPs on chromosome 1
(p-value = 2.72 × 10-12), and the TG = 49.99 of
rs2476601 was the second largest (p-value = 1.4 × 10-11,
data not shown). In this region, only SNP rs2476601
stood out; other SNPs of top 20 test scores are not
located in the region. Hence, we did not analyze
multiple SNPs.
From the results in the candidate regions on chromo-
somes 6, 9, and 1, we noticed that the highest test scores
of TH and TG were from SNPs located very close to the
candidate genes HLA-DRB1, TRAF1-C5, and PTPN22,
respectively. Therefore, the SNPs with high test scores are
of interest for further investigation to identify genes that
have modest effect on RA. In Table 2, we presented the
SNPs that showed the highest TH scores among all SNPs
of each chromosome. We chose to present the results
based on the test statistic TH, since it is more robust than
TG in terms of more stable type I error rates [7]. To make
a comparison, we presented the most significant results
from PLINK in Table 2. The SNPs identified by statistic
TH are the same as those identified by PLINK, except rank
switches on chromosomes 11 and 16. It is possible that
other SNPs that have high test scores are worthy of
further study. Due to the limited length of this article, we
could not present detailed genome-wide test data here
but we will provide detailed information on request.
Discussion
The results of our genome-wide scan provided a large
number of SNPs that have high test scores. One reason
for this is the large sample size of NARAC data. For
further study, one may start with the regions that contain
the SNPs that have highest test scores, i.e., the regions
with strongest signals. The Hotelling’s T2 tests do not
Table 1: Six SNPs on chromosome 6 and 9 with the highest test scores
Highest Test Scores of Chromosome 6 Highest Test Scores of Chromosome 9
SNP Position (bp) Test score p-Value SNP Position (bp) Test score p-Value
rs2395175 32513004 TH = 651.76 9.25 × 10
-144 rs2900180 120785936 TH = 34.21 4.95 × 10
-9
rs660895 32685358 TH= 635.76 2.79 × 10
-140 rs3761847 120769793 TH = 32.17 1.41 × 10
-8
rs6910071 32390832 TH = 527.23 1.13 × 10
-116 rs881375 120732452 TH = 31.64 1.86 × 10
-8
rs2395163 32495787 TH = 509.44 8.4 × 10
-113 rs1953126 120720054 TH = 31.19 2.34 × 10
-8
rs3763309 32483951 TH = 474.63 3.15 × 10
-105 rs10760130 120781544 TH = 30.1 4.10 × 10
-8
rs3763312 32484326 TH= 472.10 1.12 × 10
-104 rs10985073 120723409 TH = 28.16 1.12 × 10
-7
rs2395175 32513004 TG = 694.14 1.87 × 10
-151 rs2900180 120785936 TG = 34.51 3.21 × 10
-8
rs660895 32685358 TG = 653.09 1.53 × 10
-142 rs3761847 120769793 TG = 32.82 7.48 × 10
-8
rs6910071 32390832 TG = 548.25 8.89 × 10
-120 rs881375 120732452 TG = 31.88 1.19 × 10
-7
rs2395163 32495787 TG = 526.00 6.03 × 10
-115 rs1953126 120720054 TG = 31.69 1.32 × 10
-7
rs3763312 32484326 TG = 496.90 1.26 × 10
-108 rs10760130 120781544 TG = 31.27 1.62 × 10
-7
rs3763309 32483951 TG = 495.07 3.14 × 10
-108 rs10985073 120723409 TG = 29.18 4.62 × 10
-7
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adjust for population substructures. Thus, some of the
strong signals could be due to false positives. Further
study is necessary to clarify these issues.
The Hotelling’s T2 test does not include a multiplicity
adjustment. However, we can perform a very conserva-
tive (assuming independence of the tests) Bonferroni
analysis as follows. In the RA study, we analyzed
490,163 SNPs in total across the whole human genome.
Therefore, there are 490,163 TH (or TG) tests. For the
most significant SNP (rs2900180) with the highest test
scores on chromosome 9 on the right hand-side of
Table 1, the p-value of TH = 34.21 is 4.95 × 10
-9. After
adjusting for the multiple tests, the probability to get such a
result by chance is 4.95 × 10-9 * 490,163 = 0.0024. Hence,
the result is still very significant. For the least significant
SNP (rs10985073), the p-value of TH = 28.16 is 1.12 × 10
-7.
After adjusting for the multiple tests, the probability to
get such a result by chance is 1.12 × 10-7 * 490,163 =
0.055, which is close to the 0.05 significance level. The
rest of the results in Tables 1 and 2 can be analyzed
similarly.
We compared our results with those in literature [2-6]
and found them to be consistent. In addition, we
analyzed the data using PLINK and found similar results
as those of Table 1 and Table 2; partial results are
presented in Table 2. Hence, our results for analysis of
data from candidate studies and genome-wide scans
showed that the Hotelling’s tests performed well.
Furthermore, we could jointly use multiple SNPs in
analysis as we did for data of chromosomes 6 and 9.
Conclusion
We performed a genome-wide association scan for RA
data by applying Hotelling’s T2 tests. In the candidate
regions of the HLA-DRB1, TRAF1-C5, and PTPN22
genes, we identified SNPs that have the highest test
scores across chromosomes 6, 9, and 1, respectively.
Given the encouraging results in the candidate gene
regions, the regions containing SNPs with high test
scores are of interest for further investigation to map
genes which have modest effects on RA. We provided the
SNPs and their positions that had the largest scores for
each chromosome. The regions of these SNPs deserve
more investigation to map RA genes.
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Table 2: SNPs and positions of the highest TH scores on each chromosome
Chr SNP Position TH (p-value) c2 (p-value)
1 rs2476601 114089610 48.88 (2.72 × 10-12) 50.62 (1.12 × 10-12)
2 rs6433309 172343658 23.37 (1.34 × 10-6) 22.88 (1.72 × 10-6)
3 rs9290452 174045236 25.01 (5.70 × 10-7) 25.04 (5.62 × 10-7)
4 rs1388021 157757048 29.12 (6.81 × 10-8) 28.97 (7.35 × 10-8)
5 rs6596147 133075674 35.82 (2.16 × 10-9) 36.21 (1.77 × 10-9)
6 rs2395175 32513004 651.76 (9.25 × 10-144) 534.10 (3.62 × 10-118)
7 rs6978820 146629802 23.69 (1.13 × 10-6) 23.54 (1.22 × 10-6)
8 rs9785133 20402898 29.44 (5.78 × 10-8) 30.20 (3.90 × 10-8)
9 rs2900180 120785936 34.21 (4.94 × 10-9) 33.76 (6.23 × 10-9)
10 rs2671692 49767825 30.61 (3.16 × 10-8) 30.94 (2.66 × 10-8)
11 rs16935797 8077876 20.72 (5.32 × 10-6) 20.80 (5.10 × 10-6)
11 rs376813 8221633 19.1 (1.24 × 10-5) 21.33 (3.87 × 10-6)
12 rs1022232 53231332 23.01 (1.61 × 10-6) 22.81 (1.79 × 10-6)
13 rs1177637 41590823 20.28 (6.71 × 10-6) 19.96 (7.91 × 10-6)
14 rs12885166 92195035 25.38 (4.72 × 10-7) 25.53 (4.36 × 10-7)
15 rs12913832 26039213 22.11 (2.58 × 10-6) 23.27 (1.41 × 10-6)
16 rs1875206 9966508 23.92 (1.01 × 10-6) 23.81 (1.06 × 10-6)
16 rs2521669 26795854 23.64 (1.16 × 10-6) 24.08 (9.24 × 10-7)
17 rs9896052 70930457 23.00 (1.62 × 10-6) 23.53 (1.23 × 10-6)
18 rs12455894 26873793 26.23 (3.03 × 10-7) 25.61 (4.18 × 10-7)
19 rs8104309 36858686 26.89 (2.16 × 10-7) 26.15 (3.16 × 10-7)
20 rs1182531 57826397 34.96 (3.37 × 10-9) 33.67 (6.53 × 10-9)
21 rs1041778 22747323 22.72 (1.87 × 10-6) 23.25 (1.42 × 10-6)
22 rs713756 43118847 28.16 (1.12 × 10-7) 31.04 (2.53 × 10-8)
aChr, chromosome. The values of statistic c2 and the related p-values are from program PLINK http://pngu.mgh.harvard.edu/~purcell/plink/anal.shtml.
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